Inpatient Diabetes 20/01/2015. What should I do? Hyperglycaemia why does it matter? Why are the BSLs unstable? BSL parameters

Similar documents
PERIOPERATIVE DIABETES GUIDELINE

Fasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period

Peri-operative management of the surgical patient with diabetes GL059

Updated August /08/2020

Information for Patients

Clinical Guidelines. Management of adult patients with diabetes undergoing endoscopic procedures

Glucose Control drug treatments

Title Peri-operative Guidelines for the Management of Patients with Diabetes. Author s job title Diabetes Specialist Nurse Department.

How can we improve outcomes in Type 2 diabetes?

How they work and when to take them. Diabetes Medications

TREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse

YOU HAVE DIABETES. Angie O Connor Community Diabetes Nurse Specialist 25th September 2013

There have been important changes in diabetes care which may not be covered in undergraduate textbooks.

Dept of Diabetes Main Desk

Drugs used in Diabetes. Dr Andrew Smith

In-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University

DIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address:

3. Cardiovascular Disease?

Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013

The principles of insulin adjustment guidance

Mr Rab Burtun. Dr David Kim. 8:30-10:30 WS #2: Diabetes Basic 11:00-13:00 WS #9: Diabetes Basic (Repeated)

Guidelines to assist General Practitioners in the Management of Type 2 Diabetes. April 2010

Type 2 diabetes in adults: controlling your blood glucose by taking a second medicine what are your options?

Type 2 Diabetes Mellitus hypoglycaemic agents

Drug Therapy for Diabetes Mellitus. Adj A/Prof Daniel Chew Dept of Endocrinology 8 th July 2017

St Helens & Knowsley Teaching Hospitals Adult Inpatient Diabetes Management Guidelines v24

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Proposed Health Technology Appraisal

AACN PCCN Review. Endocrine

Objectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)

Objectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)

Management of Type 2 Diabetes Mellitus. Heather Corn, MD, MS Endocrinology, Diabetes, and Metabolism

667FM.5.1 MANAGEMENT OF TYPE 2 DIABETES: BLOOD-GLUCOSE-LOWERING THERAPY

Management of Adults with Diabetes Undergoing Surgery and Elective Procedures Guidelines. Diabetes Inpatient Steering Group June 2016

Wayne Gravois, MD August 6, 2017

More Than Just the Numbers:

STEP 3: Add or Substitute with one of

MANAGEMENT OF TYPE 2 DIABETES

What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin

Overview T2DM medications. Winnie Ho

Oral and Injectable Non-insulin Antihyperglycemic Agents

Navigating the New Options for the Management of Type 2 Diabetes

Pharmacological Glycaemic Control in Type 2 Diabetes

TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

Diabetes Update 10/12/2017. Section #1 OBJECTIVE. Lab features to consider:

Diabetes, Type 2 Management

Type 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions

Hot Topics: The Future of Diabetes Management Cutting Edge Medication and Technology-Based Care

Diabetes Management in New Brunswick Nursing Homes

The Many Faces of T2DM in Long-term Care Facilities

Diabetes Mellitus case studies. Jana Vinklerová

Clinical Practice Guidelines

The Death of Sulfonylureas? A Review of New Diabetes Medications

Clinical Cases in Diabetes Management. Joseph Cook D.O.

Guideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation

TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines

New Antidiabetic Medications

Table 1. Antihyperglycemic agents for use in type 2 diabetes

SIMPLICITY IN T2DM MANAGEMENT WITH DPP4 INHIBITORS: SPECIAL POPULATION

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal. Canagliflozin in combination therapy for treating type 2 diabetes

Inpatient Diabetes and Hyperglycaemia. Philip Dyer Heart of England NHS Foundation Trust Birmingham

Managing Perioperative Diabetes What s new? Kathryn A. Myers MD FRCPC Chair Chief Division of GIM Professor of Medicine Western University

SGLT2 Inhibitors

Objectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors

Peri-Operative Guidelines for Management of Diabetes Patients

Management of Women with Type I Diabetes or Insulin Treated Type II Diabetes

2/17/2016. Objectives. Define. Hey Sugar! DMII Management in Hospice Care

Staff at the Nottingham Children s Hospital. Guidelines process.

Oral Agents. Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK

Guidelines for the care of Children with Diabetes Mellitus undergoing Surgery

Arrange 3 Monthly Review Re-enforce LIFESTYLE advice and check DRUG COMPLIANCE at each visit Target HbA1c < 53mmol/mol

COMPLIANCE WITH THIS DOCUMENT IS MANDATORY

Hypoglyceamia and Exercise

7/8/2016. Sol Jacobs MD, FACE Division of Endocrinology Emory University School of Medicine

GUIDELINES FOR THE MANAGEMENT OF DIABETES IN PALLIATIVE CARE

Oral Treatments for Type 2 Diabetes. Prescribing Support Pharmacist

Diabetes and stroke. What is the link between diabetes and stroke? What is diabetes? What are the symptoms of diabetes?

PLEASE CHECK FULL SPECIFIC PRODUCT CHARACTERISTICS FOR MORE DETAILED AND CURRENT INFORMATION:

I. General Considerations

Inpatient Management of Diabetes Mellitus. Jessica Garza, Pharm.D. PGY-1 Pharmacotherapy Resident TTUHSC School of Pharmacy

Guideline for antihyperglycaemic therapy in adults with type 2 diabetes

Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors Drug Class Prior Authorization Protocol

Injectable Therapies in Diabetes

empagliflozin 10mg and 25mg tablet (Jardiance ) SMC No. (993/14) Boehringer Ingelheim / Eli Lilly

Diabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Oral Treatments. SaminaAli Prescribing Support Pharmacist

End of Life Diabetes Care

Lynda Astbury Lead Diabetes Specialist Nurse

Treatment Options for Diabetes: An Update

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery

sitagliptin, 25mg, 50mg and 100mg film-coated tablets (Januvia ) SMC No. (1083/15) Merck Sharp and Dohme UK Ltd

Country Health SA Local Health Network. Version control and change history

Insulin Therapies: An Educational Toolkit

Type 2 Diabetes Therapies and Management: An Educational Toolkit

What s New in Diabetes Medications. Jena Torpin, PharmD

TYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE

DIABETES. overview of pharmacologic agents used in the management of. Overview 4/3/2014 OBJECTIVES. Injectable Agents

Joslin Diabetes Center Joslin Diabetes Forum 2013: The Impact of Comorbidities on Glucose Control Scenario 2: Reduced Renal Function

Diabetes Mellitus. Medical Management and Latest Developments Dr Ahmad Abou-Saleh

Management of Type 2 Diabetes. Why Do We Bother to Achieve Good Control in DM2. Insulin Secretion. The Importance of BP and Glucose Control

Transcription:

Hyperglycaemia why does it matter? Inpatient Diabetes Angela Sheu Endocrine Registrar St George Hospital Hyperglycaemia at admission is a predictor of mortality May be part of stress response (eg post op, infection, AMI) Impairs recovery wounds, infection, AMI Symptoms blurred vision, polydipsia, polyuria Potentially life threatening DKA, HHS (hyperglycaemic hyperosmolar state) BSL parameters Why are the BSLs unstable? Diabetes Mellitus Random BSL > 11 Symptoms ~15 Impaired white cell function ~12 Fasting BSL >7 Most inpatients aim <10 Palliative patients <15 Gestational diabetes <7, 2hr post prandial Right medication and dose IR vs MR/XR (gliclazide, metformin) Combinations (glucovance, janumet, galvumet) Insulins (Humalog vs Humalog Mix) Altered metabolism of drug AKI Deranged LFTs Lipohypertrophy Altered glucose physiology Prednisone, infection, stress, decreased exercise Fasting, TPN/NG feeds stopped, decreased intake What should I do? Confirm medications Monitor correctly (pre meals and bedtime) Is there a pattern? Assess baseline control HBGM, BSL monitor, HbA1c, letters Look for precipitating factor Clinical presentation, comorbidities Define parameters BSL targets (usually <10) vs HbA1c (7% vs 8%) Start supplemental insulin Consider Endocrine advice 1

SGLT2 inhibitors: reduce renal glucose reabsorption Canagliflozin (Invokana) and Dapagliflozin (Forxiga) SEs: UG infections, diuresis, hypotension Not useful in egfr <60 Class Names Biguanide Metformin Extended Release Safe in renal impairment egfr >30 (lactic acidosis) Good for Everyone Bad for Lactic acidosis Sulfonylureas Glibenclamide Glimepiride Gliclazide Glipizide but more potent High BSLs Elderly* Obese Elderly* DPP-4 inhibitors Sitagliptin Linagliptin Vildagliptin Saxagliptin Alogliptin No same dose* Overweight High BSLs Thiazolidinediones Pioglitazone Rosiglitazone No NASH Heart disease Osteoporosis Peak 1hr, duration 4hrs Peak 2hr, duration 6hrs So no need to check BSLs within 1hr Supplemental insulin Better than sliding scale Pre meals ON TOP of usual insulin Use it to adjust the next day s insulins Novorapid* or actrapid <10 0 10.1 14 2 14.1 16 4 16.1 20 6 >20.1 8 <10 0 10.1 16 4 16.1 20 8 >20.1 10 <12 0 >12.1 6 2

Insulin regimens and profiles Don t WH long acting insulins if fasting BSLs are good Pre op While NBM: Monitor BSLs q4hrly IV Dextrose 5% 60-100ml/hr to keep BSLs 6-10 WH OHAs on day of surgery Consider WH nocte dose beforehand If type 2 Halve dose night before if long acting/premixed WH short acting on day of surgery If type 1 Insulin/Dextrose infusion WH short acting ONLY while NBM NEVER WH long acting insulin Post op Usually can resume pre op treatment Beware Metabolic changes AKI, hypoperfusion Nutritional status NBM, CF, FF, nausea Stress stimulus removed (eg abscess, gastric bypass) Consider temporary insulin until normal parameters Hypoglycaemia Conscious vs unconscious Lemonade + sandwich 50% Dextrose bolus will always work, but then may lead to subsequent hypoglycaemia due to insulin hypersecretion Time to recovery depends on length of action of treatment Long acting sulphonylureas or insulins will last for hours-days IV 5% dextrose at 60-80ml/hr until BSL >8-10 3

Other questions The fasting BSL is 4.1 and the patient is allowed to eat and is charted 20units of NovoMix30 do I give it? Is this the usual dose? The bedtime BSL is 6.7 and the patient is not NBM and is charted 20units of Lantus do I give it? Is this the usual dose? It is 20:00 (>2hr post prandial) and the patient s BSL is 15 what do I do? When was the patient last given insulin? It is 20:00 (>2hr post prandial) and the patient s BSL is 25 what do I do? Novorapid 4-8 units DKA Type 1 = absolute insulin deficiency Hyperglycaemia Ketone production Metabolic acidosis Diabetic Emergencies HHS Type 2 = relative insulin deficiency Hyperglycaemia++ Hyperosmolar Fluid deficit Which has the higher mortality? 1. Confirm Dx V/ABG, ketones, UA 2. Find the cause FBC, troponin, septic screen 3. Assess the damage EUC, CMP, LFT, osmolality 4. Baseline HbA1c, antibodies (anti- GAD, islet cells, insulin), insulin, c-peptide 1. Insulin infusion 50u in 500ml NS = 1u/10ml <2.5u/hr = no hypo. No upper limit Overlap IV and SC insulin 2. Hydration correct deficits first (>6L) Total K deficit concurrent K if K<4 Beware Na and pseudohyponatremia Treat other electrolytes (Mg, PO4) 3. Treat the cause 4. Prevent cx actrapid 500ml N/S 1 10 10 <6 + IV dextrose 20 6-10 + IV dextrose 30 10-20 40 20-25 50 >25 Beware ward vs ED/HDU concentrations Rate is ml/hr not u/hr In general, don t stop the insulin infusion (commence IV Dextrose 5% 100ml/hr) I need help! Diabetes Educator #127 Diabetes education Starting insulin Titrating insulin Endocrine team #904 Unstable BSLs Insulin temporarily Perioperatively Enteral nutrition All type 1, GDM, brittle type 2 Getting phone advice is allowed BUT I need the BSLs 4

Calling Endocrine Calling Endocrine Type of Diabetes Length of disease (ie new, longstanding) Usual treatment (+/- compliance, control) Current presentation The issue In hospital hyper/hypoglycaemia New diagnosis Poor control with complications Reduced oral intake/nbm/periop/ng feeding I am calling about a 58M with known T2DM, on levemir 15U and metformin 500mg, who is day 1 post left foot amputation for a gangrenous toe. His HbA1c is 9%. His sugars in hospital have all been <10 on no treatment. Do we restart his treatment? Who is he known to? Why is he on this regimen? Is he compliant? What are his other complications? I am calling about an 84M with known T2DM, known to your clinic, who has high BSLs in hospital. He is D10 post NOF# after a fall. He is normally on gliclazide 90mg. He has an egfr of 45. His HbA1c is pending. Can you optimise his treatment? Why is he still in hospital? What is his DC plan? When are the BSLs high? Is this his baseline renal function? Case 1 94M, lives at home alone, presented with syncope, awaiting cardiac investigations. Normally on glicazide MR 60mg, metformin 1g BD and lantus 40u nocte. BSLs in hospital have been consistently >15, despite being treated with sliding scale actrapid. HbA1c = 7%. How does this change your mx? HbA1c = 9%. How does this change your mx? Case 2 72M inferior STEMI, for CABG. Known T2DM, on glicazide MR 60mg BD and metformin 1g BD, but known noncompliance. BSLs is hospital 10-20, on sliding scale actrapid. HbA1c = 9%. How does this change your mx? HbA1c = 18%. How does this change your mx? 5

Case 3 45M, NESB, known T2DM, on gliclazide MR 60mg BD and metformin 1g BD. Presents with *something* and now needs prednisone. HbA1c = 7%. How does this change your mx? HbA1c = 9%. How does this change your mx? Key points Chart supplemental insulin, but use it to guide your regular prescription Insulins are like warfarins if charted daily, it should be the day team therefore chart the next 24 hours (including mane doses) If in doubt, monitor more frequently Careful with NG, TPN feeding and perioperatively Don t be afraid to ask for help I would prefer to know earlier rather than later Call about all type 1 patients and don t WH their basal insulin! 6